1.2 Federal vs. State Law Hierarchy & Stricter Law Rule
Key Takeaways
- The U.S. Constitution's Supremacy Clause establishes federal preemption, but state police powers (Tenth Amendment) permit states to enact stricter pharmacy and public health laws.
- Under the foundational 'Stricter Law Rule,' whenever federal and state laws address the same topic, the pharmacist must always adhere to the more stringent, restrictive, or exacting standard.
- 'Stricter' means requiring more documentation/affirmative action, setting earlier expirations/shorter day supplies, demanding longer record retention, or classifying drugs into more restrictive schedules.
- Key Kentucky strictures include: C-II 60-day prescription expiration (federal = indefinite), C-II acute pain opioid 3-day supply limit (federal = no day limit), 5-year record retention (federal = 2 years), and Gabapentin scheduled as C-V (federal = non-controlled).
- Kentucky does NOT recognize the federal exemption for butalbital combination products (Fioricet is Schedule III in Kentucky).
1.2 Federal vs. State Law Hierarchy & Stricter Law Rule
In the United States, the practice of pharmacy is governed by a dual-sovereignty legal architecture. Federal law establishes a nationwide baseline of drug safety, interstate commerce regulation, and controlled substance distribution. Simultaneously, the Tenth Amendment to the United States Constitution reserves general "police powers" to the individual states, granting them plenary authority to regulate professional occupations and protect the health, safety, and welfare of their citizens. Navigating this intersection requires mastery of the Stricter Law Rule.
1. Constitutional Supremacy & Federal Preemption
Under Article VI, Clause 2 of the United States Constitution (the Supremacy Clause), federal law is the supreme law of the land. When a direct, irreconcilable conflict arises between federal law and state law, federal law preempts (displaces) state law.
┌─────────────────────────────────────────────────────────────────────────────┐
│ FORMS OF FEDERAL PREEMPTION │
├─────────────────────┬───────────────────────────────────────────────────────┤
│ Express Preemption │ Congress explicitly writes statutory language stating │
│ │ that state regulation is barred (e.g., medical device │
│ │ pre-market approvals under the FDCA). │
├─────────────────────┼───────────────────────────────────────────────────────┤
│ Field Preemption │ Federal regulation is so pervasive that it leaves no │
│ │ room for states to supplement it. │
├─────────────────────┼───────────────────────────────────────────────────────┤
│ Conflict Preemption │ Occurs when: │
│ │ 1. It is physically impossible to comply with both │
│ │ federal and state laws simultaneously; or │
│ │ 2. State law stands as an obstacle to achieving │
│ │ Congress's full objectives. │
└─────────────────────┴───────────────────────────────────────────────────────┘
The Controlled Substances Act (CSA) Anti-Preemption Clause
Critically, the federal Controlled Substances Act (21 U.S.C. § 903) contains an explicit anti-preemption provision: Congress declared that federal controlled substance law does not occupy the field or displace state drug laws unless there is a positive conflict where simultaneous compliance is impossible. Because a state law that is more restrictive than federal law can be complied with without violating federal law, more stringent state pharmacy laws are entirely valid and enforceable.
2. The Core Principle: The Stricter Law Rule
In pharmacy jurisprudence, the operational rule is unambiguous:
The Stricter Law Rule: Whenever federal law and state law regulate the exact same subject matter, transaction, or substance, the pharmacist, intern, technician, and pharmacy permit holder must always obey the stricter, more stringent, or more restrictive law.
Compliance with the stricter standard inherently satisfies the less demanding standard, ensuring full legal compliance across both federal and state jurisdictions.
What Constitutes "Stricter" in Pharmacy Law?
A law is considered stricter if it satisfies any of the following five criteria:
- Requires More Positive Action / Verification: Demands additional documentation, mandatory verbal offers to counsel, electronic PDMP queries, or security features.
- Imposes Shorter Timeframes / Earlier Expirations: Reduces the validity period of a prescription (e.g., C-II expiring in 60 days vs. never expiring federally).
- Limits Quantities or Refills More Severely: Caps the maximum day supply (e.g., 3-day acute opioid limit) or prohibits refills.
- Imposes Longer Record Retention Periods: Mandates keeping transaction, dispensing, and inventory logs for a greater number of years (e.g., 5 years in KY vs. 2 years federal).
- Classifies a Drug in a More Restrictive Schedule: Treats a non-controlled substance as a controlled substance, or moves a Schedule IV/V drug into Schedule III.
3. High-Yield Federal vs. Kentucky Law Comparisons
Mastery of the specific differences between federal baselines and Kentucky strictures is the single highest-yield skill on the Kentucky MPJE. The following table provides direct comparative analysis across core regulatory topics:
| Regulatory Topic | Federal Baseline | Kentucky Law Standard | Prevailing Rule & Legal Reference |
|---|---|---|---|
| Schedule II Prescription Expiration | No federal expiration date (valid indefinitely under 21 CFR § 1306.11 unless state law sets a limit). | Valid for exactly 60 days from the date issued (KRS 218A.180). | Kentucky Rule Prevails (60 Days). Prescription void on day 61. |
| Schedule II Acute Pain Opioid Limit | No federal day-supply limit on initial or acute pain prescriptions. | 3-day supply maximum for acute pain, subject to narrow statutory exceptions (KRS 218A.205). | Kentucky Rule Prevails (3-Day Limit). Excess quantities prohibited for acute pain. |
| Controlled Substance Record Retention | 2 years for all executed Form 222s, invoices, inventories, and Rx files (21 CFR § 1304.04). | 5 years for all prescription records, inventories, and controlled substance transactions (KRS 315.191, KRS 218A.200). | Kentucky Rule Prevails (5 Years). All records must be retrievable for 5 years. |
| Prescription & Patient Profile Records | 2 years under general federal regulations. | 5 years from the date of the last dispensing or entry (201 KAR 2:210, KRS 315.191). | Kentucky Rule Prevails (5 Years). |
| Pseudoephedrine Daily Sales Limit | 3.6 grams per day of pseudoephedrine base per purchaser (Combat Methamphetamine Epidemic Act). | No separate state daily cap — the federal 3.6 g/day applies in Kentucky through the CMEA. | 3.6 g/day (federal). Logged through an Office of Drug Control Policy-approved electronic system (NPLEx). |
| Pseudoephedrine 30-Day Sales Limit | 9.0 grams per 30 days (7.5 g for mail-order / mobile retail). | 7.2 grams per 30 days (KRS 218A.1446(5)); the former annual cap was repealed effective July 15, 2024. | Kentucky Rule Prevails (7.2 g / 30 days). Stricter than the federal 9.0 g; there is no longer a Kentucky annual ceiling. |
| Gabapentin (Neurontin) Classification | Non-controlled legend drug (prescription required, but not a controlled substance under federal CSA). | Schedule V Controlled Substance (902 KAR 55:015; monitored in KASPER, subject to C-V rules). | Kentucky Rule Prevails (Schedule V). Reported to KASPER; 60-day or 6-month validity rules apply. |
| Butalbital / APAP / Caffeine (Fioricet) | Exempt prescription product (non-controlled federally due to butalbital-to-acetaminophen ratio). | Schedule III Controlled Substance (Kentucky does NOT recognize federal exemption under 902 KAR 55:045). | Kentucky Rule Prevails (Schedule III). Max 5 refills, expires in 6 months, security blank required. |
| Nalbuphine (Nubain) Classification | Non-controlled legend drug under federal law. | Schedule IV Controlled Substance under Kentucky law (902 KAR 55:015). | Kentucky Rule Prevails (Schedule IV). Subject to all C-IV transfer, refill, and storage rules. |
| Non-Rx (Exempt) Codeine Cough Syrups | Permits pharmacist OTC exempt narcotic sales (<= 120 mL of a non-opium controlled substance per purchaser per 48 hours, age 18+, under 21 CFR § 1306.26). | Also permitted, with statutory conditions (KRS 218A.190): <= 200 mg codeine/100 mL, additional medicinal ingredients, pharmacist-only sale, age 18+, not publicly displayed, <= 120 mL per person per 48 hours, separate registry. | Both allow the sale — Kentucky adds conditions. This is a rare topic where Kentucky is not an outright ban; apply the KRS 218A.190 checklist. |
| Pentazocine / Barbituric Acid Derivatives | Schedule IV under 21 CFR 1308.14. | Schedule III under 902 KAR 55:015 (pentazocine, barbital, methylphenobarbital, phenobarbital). | Kentucky Rule Prevails (Schedule III). Security blank required; 5 refills / 6 months. |
| Patient Counseling Mandate | OBRA '90: Mandatory offer to counsel Medicaid outpatients on new prescriptions. | 201 KAR 2:210: Offer to counsel required on every original prescription order regardless of payor; on refills as professional discretion dictates for ALL patients. | Kentucky Rule Prevails. Verbal offer required in-person on all outpatient dispensings. |
| PDMP Electronic Reporting Window | No federal reporting mandate (states manage individual PDMP databases). | Mandatory reporting within 1 business day (24 hours) of dispensing any Schedule II–V drug (KRS 218A.202). | Kentucky Rule Prevails (1 Business Day to KASPER). |
4. Exceptions & Boundaries to State Preemption
While states possess broad power to enact stricter standards, there are specific boundaries where federal authority is exclusive and absolute:
- FDA Approved Product Labeling & Black Box Warnings: A state board of pharmacy cannot permit a pharmacist to omit FDA-mandated Black Box Warnings, alter official package insert indications, or dispense prescription-only legend medications without a valid practitioner order.
- Federal REMS Programs: Risk Evaluation and Mitigation Strategies (REMS) established under the Food and Drug Administration Amendments Act (FDAAA) of 2007 represent strict federal safety baselines. A state cannot waive REMS enrollment, prescriber certification, or lab-monitoring mandates (e.g., Clozapine REMS absolute neutrophil count verification, Isotretinoin iPLEDGE pregnancy verification).
- Federal Government Facilities: Military pharmacies, Veterans Affairs (VA) hospitals, and Indian Health Service (IHS) clinics operating on federal land fall under exclusive federal jurisdiction. Pharmacists practicing within these federal institutions need only hold an active license in any U.S. state and are exempt from state-specific licensure and state-level restrictions while performing official duties.
5. Step-by-Step Decision Algorithm for Exam Items
When faced with an MPJE question involving potential legal conflict or regulatory parameters, follow this systematic four-step sequence:
┌─────────────────────────────────────────────────────────────────────────────┐
│ FOUR-STEP MPJE JURISPRUDENCE FRAMEWORK │
├─────────────────────────────────────────────────────────────────────────────┤
│ Step 1: Identify Subject Matter & Substance Class │
│ └─> What drug or activity is involved? (e.g., C-II, Gabapentin, Fioricet) │
│ │
│ Step 2: Retrieve Federal CSA / FDCA Baseline Requirements │
│ └─> What does federal law dictate? (e.g., 2-year records, no C-II exp) │
│ │
│ Step 3: Retrieve Kentucky Specific Statutes (KRS) & Regulations (KAR) │
│ └─> What does Kentucky dictate? (e.g., 5-year records, 60-day C-II exp) │
│ │
│ Step 4: Apply the Stricter Standard (Unless Preempted) │
│ └─> Select the standard that offers greater control, shorter validity, │
│ or more comprehensive patient protection. │
└─────────────────────────────────────────────────────────────────────────────┘
A community pharmacist in Lexington receives a written prescription for Oxycodone 10 mg tablets written for a 30-day supply to treat acute lower back pain following a motor vehicle collision. The prescription is dated 45 days prior to the date it is presented at the pharmacy. How should the pharmacist handle this prescription under Kentucky law?
A prescriber in Louisville writes an outpatient prescription for Fioricet (butalbital 50 mg / acetaminophen 325 mg / caffeine 40 mg) with 5 refills. Under federal law, this specific combination product is exempt from controlled substance scheduling. How is this prescription regulated in the Commonwealth of Kentucky?
A retail pharmacy is audited by regulatory inspectors. Which of the following comparative statements regarding record retention and pseudoephedrine limits correctly reflects the stricter Kentucky standard?